The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib study of anlotinib plus TQB2450 as a second-line investigational therapy in advanced hepatocellular carcinoma (aHCC).
 
Wen Zhang
No Relationships to Disclose
 
Yongkun SUN
No Relationships to Disclose
 
Huiying Zeng
No Relationships to Disclose
 
Zheng Zhu
No Relationships to Disclose
 
Meng Liang
No Relationships to Disclose
 
Yue Han
No Relationships to Disclose
 
Dong Yan
No Relationships to Disclose
 
BO CHEN
No Relationships to Disclose
 
Zhen Huang
No Relationships to Disclose
 
Xinyu Bi
No Relationships to Disclose
 
Hong Zhao
No Relationships to Disclose
 
Ai-Ping Zhou
Consulting or Advisory Role - Novartis; Pfizer